MMB — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-11 in 3mo
ESTIMATED |
READOUT
Extended Access of Momelotinib in Adults With Myelofibrosis
Phase 2 · Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF) |
GlaxoSmithKline | MMB |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|